New Horizon 2020 MSCA-ITN-EJD EU project at the Institute of Biomaterials
A new EU consortium with participation of the Institute of Biomaterials (Principal Investigator: Prof. Aldo R. Boccaccini) focusing on tendon regeneration has been awarded a 4.1 M€ grant from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie Innovative Training Networks European Joint Doctorates (MSCA-ITN-EJD) (grant agreement No 955685). The project “Perspectives for Future Innovation in Tendon Repair” (P4 FIT) will train a new generation of 15 early stage researchers (ESRs) in the interdisciplinary fields of biomaterials, nanomedicine, drug delivery and tissue engineering. Project coordinator is Professor Helder Santos, from the Faculty of Pharmacy, University of Helsinki. The P4 FIT project brings together world-renowned academic and non-academic EU institutions, covering key basic and technological disciplines to launch a unique European joint doctorate. The inter-disciplinary, inter-sectoral, and international high quality educational environment will deliver innovation-driven training and research leadership, grounded in excellence, to provide innovation in tendon medicine to tackle the urgent societal/economic healthcare demand determined by the worldwide growing incidence of tendinopathy. The consortium consists of the following six beneficiaries:
- Faculty of Pharmacy – University of Helsinki (FI, Coordinator, Prof. Hélder A. Santos)
- Friedrich Alexander University Erlangen-Nuremberg (DE; Leader: Prof. Aldo R. Boccaccini)
- Università degli Studi di Teramo (IT; Leader: Prof. Valentina Russo)
- Università degli Studi di Salerno (IT; Leader: Prof. Prof. Nicola Maffulli)
- Medical University of Vienna (AT; Leader: Prof. Johannes Stöckl)
- University of Keele (UK; Leader: Prof. Nicholas Forsyth).
P4 FIT also involves 21 partner organizations, 10 academic and 11 non-academic institutions from across the whole Europe and it will enable cross-disciplinary research. This four-year project will begin in January 2021.